# A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

> **NCT05890950** · PHASE1 · COMPLETED · sponsor: **Kallyope Inc.** · enrollment: 24 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes Mellitus in Obese

## Interventions

- **DRUG:** K-757 and K-833
- **DRUG:** Matching placebo to K-757 and K-833

## Key facts

- **NCT ID:** NCT05890950
- **Lead sponsor:** Kallyope Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-13
- **Primary completion:** 2023-07-12
- **Final completion:** 2023-07-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890950, "A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05890950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*